Company news and developments, with original sources and dates.
Updated from source·Oct 20, 2026, 18:05 UTC
On August 6, 2026, per Labiotech, natural product drug discovery company LifeMine Therapeutics raised $188M in a Series E. Industry coverage in September 2026 noted an additional ~$75M Series D during August; the two rounds should not be combined into a single figure. Details are subject to company announcements.